Studies on bladder cancer cell lines suggest that ARRB2 negatively regulates the cancer stem cell (CSC) marker Aldehyde dehydrogenase (ALDH) [41], which is implicated in the maintenance of CSC stemness and is important for the progression of bladder cancer [40,42]. Here, ARRB2 is linked to urinary bladder carcinoma.